Comparison of Campath and Rebif Treatment on Cognition in Multiple Sclerosis (MS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00914758
Recruitment Status : Unknown
Verified June 2009 by Washington Neuropsychology Research Group.
Recruitment status was:  Enrolling by invitation
First Posted : June 5, 2009
Last Update Posted : June 5, 2009
Genzyme, a Sanofi Company
Information provided by:
Washington Neuropsychology Research Group

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : October 2011
  Estimated Study Completion Date : December 2011